Scientific ReportsMolecular BiologyPeer-reviewed journal article
Evolution of SARS-CoV-2 spike trimers towards optimized heparan sulfate cross-linking and inter-chain mobility
Jurij Froese, Marco Mandalari, Monica CiveraiD, Stefano ElliiD, Isabel PaganiiD, Elisa VicenziiD, Itzel Garcia‐MongeiD, Daniele Di IorioiD, Saskia Frank, Antonella BisioiD, Dominik LenhartiD, Rudolf Gruber, Edwin Alexander YatesiD, Ralf P. RichteriD, Marco GuerriniiD, Seraphine Valeska WegneriD, Kay GrobeiD
Abstract
The heparan sulfate (HS)-rich extracellular matrix (ECM) serves as an initial interaction site for the homotrimeric spike (S)-protein of SARS-CoV-2 to facilitate subsequent docking to angiotensin-converting enzyme 2 (ACE2) receptors and cellular infection. Recent variants of concern (VOCs), notably Omicron, have evolved by swapping several amino acids to positively charged residues to enhance the S-protein trimers interaction with the negatively charged HS polysaccharide chains in the matrix. These increased interactions, however, may reduce Omicrons ability to move through the HS-rich ECM to effectively find ACE2 receptors and infect cells, and raise the question of how HS-associated virus movement can be mechanistically explained. In this work, we show that Omicron S-proteins have evolved to balance HS interaction stability and dynamics, resulting in enhanced mobility on an HS-functionalized artificial matrix. Both properties are achieved by the ability of Omicrons S-proteins to cross-link at least two HS chains, providing both high avidity to retain the protein inside the HS-rich matrix, and fast dynamics, thus enabling direct S-protein switching between HS chains as a prerequisite for mobility at the cell surface. Optimized HS interactions can be targeted pharmaceutically, because an HS mimetic significantly suppressed surface binding and cellular infection specifically of the Omicron VOC. These findings suggest a robust way to interfere with SARS-CoV-2 Omicron infection and, potentially, future variants.
- Citations
- 8
- FWCI
- 2.75
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Variant-specific interactions at the plasma membrane: Heparan sulfate's impact on SARS-CoV-2 binding kinetics
D. V. Conca, F. Bano, … M. Bally·bioRxiv·Jan 10, 2024
- Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2
C. Planchais, A. Reyes-Ruiz, … J. D. Dimitrov·bioRxiv·Jun 11, 2022
- The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
G. Paiardi, M. Ferraz, … R. C. Wade·bioRxiv·Feb 5, 2024
- Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage
N. Shiliaev, T. Lukash, … I. Frolov·bioRxiv·Jun 28, 2021
- Nanoscopy Reveals Heparan Sulfate Clusters as Docking Sites for SARS-CoV-2 Attachment and Entry
Sue Han, Xin Wang, … Ling‐Gang Wu·bioRxiv·Sep 8, 2025
- Spike protein of the SARS-CoV-2 omicron variant interacts with actin
Ai Fujimoto, Haruki Kawai, … Akira Kitamura·CellsPeer-reviewed·Aug 7, 2024